37663-46-0 Usage
Description
Spiro[isobenzofuran-1(3H),4'-piperidin]-3-one is a complex organic compound that features a spiro linkage between an isobenzofuran and a piperidine ring. This unique structure endows it with specific chemical properties and potential applications in various fields.
Uses
Used in Pharmaceutical Industry:
Spiro[isobenzofuran-1(3H),4'-piperidin]-3-one is used as a key intermediate in the synthesis of cyclin-dependent kinase (CDK) inhibitors. These inhibitors are important for the development of drugs targeting various diseases, including cancer, by disrupting the cell cycle and preventing uncontrolled cell proliferation.
Used in Research and Development:
In the field of medicinal chemistry, Spiro[isobenzofuran-1(3H),4'-piperidin]-3-one serves as a valuable building block for the design and synthesis of novel compounds with potential therapeutic applications. Its unique structure allows researchers to explore new avenues in drug discovery and development.
Used in Chemical Synthesis:
Spiro[isobenzofuran-1(3H),4'-piperidin]-3-one can be utilized in the synthesis of various organic compounds, including pharmaceuticals, agrochemicals, and other specialty chemicals. Its versatile structure makes it a useful component in the creation of new molecules with desired properties and functions.
Check Digit Verification of cas no
The CAS Registry Mumber 37663-46-0 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 3,7,6,6 and 3 respectively; the second part has 2 digits, 4 and 6 respectively.
Calculate Digit Verification of CAS Registry Number 37663-46:
(7*3)+(6*7)+(5*6)+(4*6)+(3*3)+(2*4)+(1*6)=140
140 % 10 = 0
So 37663-46-0 is a valid CAS Registry Number.
37663-46-0Relevant articles and documents
INDOL-3-YL-CARBONYL-SPIRO-PIPERIDINE DERIVATIVES AS V1A RECEPTOR ANTAGONISTS
-
Page/Page column 38; 40; 67, (2008/06/13)
The invention relates to indol-3-yl-carbonyl-spiro-piperidine derivatives which act as V1a receptor antagonists and which are represented by Formula I: wherein the spiro-piperidine head group A and the residues R1, R2 and R3 are as defined herein. The invention further relates to pharmaceutical compositions containing such compounds, methods for preparing the compounds and pharmaceutical compositions, and their use in the treatment of dysmenorrhea, hypertension, chronic heart failure, inappropriate secretion of vasopressin, liver cirrhosis, nephrotic syndrome, obsessive compulsive disorder, anxious and depressive disorders.
Spiro piperidines. I. Synthesis of spiro[isobenzofuran 1(3 H),4' piperidines] and spiro[isobenzofuran 1(3 H),3' piperidines]
Marxer,Rodriguez,McKenna,Tsai
, p. 1427 - 1433 (2007/10/05)
-